ELIXIR PHARMA
Business purpose.
La distribution en gros de médicaments à usage humain ou à usage vétérinaire, de dispositifs médicaux, de matières premières à usage pharmaceutique et de tout produit de santé à usage thérapeutique
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 1 Apr 2024
- Share capital
- 30,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 1
Directors
- Samer SAYAH 44 years old, 01/1982 Directeur general
- Information not disclosable President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- ALTEA PHARMA via Samer SAYAH
- SAMER SAYAH via Samer SAYAH
- POTION PHARMA via Samer SAYAH
- LXR via Samer SAYAH
- LIS PHARMA via Samer SAYAH
Establishments
Financial strength
Financial score
26 / 100 E
Confidence: low · computed on the financial year ended 31 Dec 2024
- Equity to assets (7.8 %)
- 6.0 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (115.1 %)
- 4.3 out of 20
- Debt (147.2 %)
- 6.4 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
85 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (2.5 years)
- 5.1 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 0 € | first year on record | 0 € | 134,510 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la répartition pharmaceutique du 7 janvier 1992. Etendue par arrêté du 28 juillet 1992 JORF 29 juillet 1992.
IDCC 1621 · in force, extended · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 13 Oct 2026
- Court :
- Greffe du Tribunal des Activités Economiques de versailles
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260196, annonce n 9969 · Proof of publication (PDF)
-
Amendment 9 Oct 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Versailles
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20260194, annonce n 3030 · Proof of publication (PDF)
-
Filing of accounts 24 Oct 2025
- Court :
- Greffe du Tribunal des Activités Economiques de versailles
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250205, annonce n 9024 · Proof of publication (PDF)
-
Amendment 28 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de Versailles
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20240145, annonce n 3676 · Proof of publication (PDF)
-
Incorporation 11 Apr 2024
- Court :
- Greffe du Tribunal de Commerce de Versailles
BODACC A n 20240072, annonce n 1378 · Proof of publication (PDF)
Filings and accounts
- Formality 6 Oct 2026
- Formality 25 Jul 2024
- Formality 9 Apr 2024
Change history
- officer_removed Commissaire aux comptes titulaire → (empty) 9 Oct 2026
- officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address (empty) → 53 Rue des Fontenelles 78920 Ecquevilly 2 Oct 2026
- capital (empty) → 30000.00 2 Oct 2026